Written by the AllMyPeptides Research Team
What Is KPV?
KPV is a tripeptide (lysine-proline-valine) that corresponds to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). It is studied for its anti-inflammatory properties independent of pigmentation activity.
Research use only. This material is supplied for in-vitro laboratory research. It is not a medicine and is not for human or veterinary consumption, administration, or therapeutic use.
How KPV Is Studied to Work
In research KPV is associated with down-modulation of pro-inflammatory signalling and has been examined in cell and animal models of inflammation, including gastrointestinal (inflammatory bowel) models and wound-healing contexts. It is studied for its small size and stability.
Evidence & Regulatory Status
The KPV evidence base is preclinical, with limited human data. KPV is not approved as a medicine by the MHRA and is supplied for laboratory research only.
Research Handling & Quality
As a lyophilised (freeze-dried) peptide it is typically stored frozen and reconstituted with bacteriostatic water for in-vitro work — see our reconstitution guide and storage guide. Identity and purity should be verified against a batch-matched Certificate of Analysis (COA) with HPLC and mass-spectrometry data. View kpv product details and COA.
Frequently Asked Questions
Is KPV approved in the UK?+
Where does KPV come from?+
Is KPV related to BPC-157?+
Related Guides
Products discussed in this guide are for research and laboratory use only. AllMyPeptides does not condone or support misuse of any research materials. Not for human or animal consumption.